AI Science Tracker

Machine learning guides refinement of DNA aptamers binding NGAL

Google Research; Aptitude Medical Systems · 22 Apr 2021 · biology

Discovery

Machine learning guides refinement of DNA aptamers binding NGAL

Neural models trained on particle-display affinity-screening data guided sequence mutation and candidate nomination, followed by synthesis and experimental affinity testing. The authors report a 23-nucleotide truncation of candidate G13 with measured dissociation constant 1.5 nM, compared with about 8 nM for the full-length parent under their assay. This is a binding result, not demonstrated diagnostic or therapeutic efficacy. The screening set is not 187,499 independently validated agents; sequence-level prior art remains open.

Technology: Neural-network models trained on particle-display affinity data

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The study reports particle-display screening and measured NGAL binding, including full Kd for truncated and parent G13.
  • Still unknown: Binding assay only; no diagnostic/therapeutic outcome; one holdout set used for tuning and sequence novelty requires further review.
  • AI role: Trained neural models extrapolated from experimentally measured sequences to nominate and iteratively refine higher-affinity DNA aptamers and truncations.

Evidence sources: https://www.nature.com/articles/s41467-021-22555-9

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary publisher indexed full text, article dates, methods/results, affiliations and disclosed limitations..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.